Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A nested case-control study of dabigatran, apixaban, and rivaroxaban

Next Previous
Trial Profile

A nested case-control study of dabigatran, apixaban, and rivaroxaban

Completed
Phase of Trial: Phase IV

Latest Information Update: 20 Sep 2018

At a glance

  • Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
  • Indications Venous thromboembolism
  • Focus Therapeutic Use

    • Most Recent Events

    • 20 Sep 2018 New trial record
    • 26 Aug 2018 Results presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top